Detalhe da pesquisa
1.
A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.
BMC Pulm Med
; 20(1): 119, 2020 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32366249
2.
A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
Respir Res
; 19(1): 38, 2018 03 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29506504
3.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 8, 2017 01 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28061907
4.
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
Respir Res
; 17(1): 109, 2016 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27586537
5.
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 158, 2017 08 21.
Artigo
Inglês
| MEDLINE | ID: mdl-28826397
6.
ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting.
Chronic Obstr Pulm Dis
; 7(2): 118-129, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32324983
7.
The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.
Chronic Obstr Pulm Dis
; 6(4)2019 Oct 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31647856
8.
Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease.
Respir Med
; 138: 74-80, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29724397
9.
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD.
Chest
; 151(2): 340-357, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27916620
10.
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
Int J Chron Obstruct Pulmon Dis
; 11: 1233-43, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27354782
11.
Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect.
Int J Chron Obstruct Pulmon Dis
; 9: 919-25, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25214778
12.
Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
J Aerosol Med Pulm Drug Deliv
; 27(6): 478-87, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24745666
13.
Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study.
Pulm Pharmacol Ther
; 22(1): 44-9, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19071226